Aflac AFL Cancer — Less: reinsurance recoverable
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Aflac in its filing.
Tagged under the XBRL concept us-gaap:LiabilityForFuturePolicyBenefitReinsuranceRecoverableAfterAllowance.
The official record: Aflac’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aflac's cancer — less: reinsurance recoverable.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Aflac's cancer — less: reinsurance recoverable?
- Aflac (AFL) reported cancer — less: reinsurance recoverable of $4.14B in Q1 2026.
- How has Aflac's cancer — less: reinsurance recoverable changed year-over-year?
- Aflac's cancer — less: reinsurance recoverable decreased by 19.7% year-over-year, from $5.16B to $4.14B.
- What is the long-term trend for Aflac's cancer — less: reinsurance recoverable?
- Over 2 years (2023 to 2025), Aflac's cancer — less: reinsurance recoverable has grown at a 54.4% compound annual growth rate (CAGR), from $8.22B to $19.58B.
- What does cancer — less: reinsurance recoverable mean?
- The portion of the cancer insurance liability that is ceded to reinsurers, representing the amount the company expects to recover from third-party insurers. This reduces the net risk exposure of the segment.